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Abstract
Due to poor diagnostic facilities and a lack of medical alertness, allergy to Vespa wasps may be underestimated. Few
allergens have been identified from Vespa wasps. Possible native allergen proteins were purified from the wasp venoms
(WV) (Vespa magnifica Smith) by gel filtration, ion exchange chromatography, respectively. Their sequences were
determined by Edman degradation and cDNA cloning. Their allergenicities were assayed by enzyme-linked immunosorbent
assay inhibition tests (ELISA-IT), immunoblots, and skin prick tests (SPTs). Their cross allergencities with Tab y 2 and Tab y 5
purified from the horsefly (Tabanus yao Macquart) were also determined. Two native allergens were identified from the WV,
respectively. They are a 25-KDa antigen 5 protein (Ag5) (Vesp ma 5) and a 35-KDa hyaluronidase (Vesp ma 2). They
represented major allergens in Vespa magnifica by immunoblots and SPTs. ELISA inhibition of pooled sera IgE reactivity to
both the WV and the horsefly salivary gland extracts (HSGE) using four purified allergens (Vesp ma 2, Vesp ma 5 and
previously purified Tab y 2 and Tab y 5) was significant. Their cross allergenicities were confirmed by ELISA-IT, immunoblots,
and SPTs. They represented the cross reactive allergens from wasp and horsefly and proved the so called wasp-horsefly
syndrome.
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Introduction
Anaphylaxis from insect venom is mostly caused by Hymenop-
tera stings, including vespids of the genera Vespula, Vespa,
Dolichovespula, and Polistes and by apids of the genera Apis and
Bombus. Three ant genera are also of importance: Solenopsis,
Myrmecia and Pachycondyla [1–5]. Many cases of wasp allergy with
severe allergic reactions have been documented. The symptoms
induced by wasp allergy include itch, urticaria, angioedema,
bronchial constriction, shock, pharyngeal constriction, shortness of
breath, unconsciousness, nausea, vomiting, shivers and profuse
perspiration, which are similar to the allergic symptoms induced
by stinging from other insects of the order of Hymenoptera.
There are more than 24 species in the genus of Vespa wasps
but allergens are only found in the venoms of Vespa crabro [6,7].
Due to poor diagnostic facilities and a lack of medical alertness,
allergy to Vespa wasps may be underestimated. Few allergens
have been identified from Vespa wasps. They are Vesp c 5
(Antigen 5) and Vesp c 1 (Phospholipase A1) [6,7]. However,
these two allergens’ allergenicity is poorly understood. Further-
more, considering coexistent anaphylaxis to Diptera and
Hymenoptera, concomitant sensitization to Hymenoptera ven-
o m si ns u b j e c t sa l l e r g i ct oh o r s e f l i e ss e e m st ob ef r e q u e n t( T h e
wasp-horsefly syndrome) [8–10]. However, no cross-reactive
allergens, which contribute to the coexistent anaphylaxis to
Vespa wasp and horsefly, are known.
Many active compounds with anti-coagulation, anti-platelet,
anti-inflammation, and immunosuppressant activities were isolat-
ed from the Vespa wasp, Vespa magnifica [11–15]. However, no
allergens from the venom of V. magnifica have been purified and
characterized. In the present study, we purified and characterized
two novel allergens that we named Vesp ma 2 and Vesp ma 5
from the venom of V. magnifica and investigated their allergenicity.
Materials and Methods
Ethics Statement
The study protocol was approved by the ethics committee of the
Institutional Review Board of the Kunming Institute of Zoology,
Chinese Academy of Sciences.Written informed consent for the
use of blood samples and skin test were obtained from all
participants before study entry. We also obtained written informed
consent from the next of kin, carers or guardians on the behalf of
the minors/children participants involved in our study.
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Sera were obtained from 33 subjects with wasp allergy, 12
childrenage6to18years(mean12.6years)and21adultsage19–61
years (mean 41.2 years). They share similar allergic reactions
including some of the symptoms of itch, urticaria, angioedema,
bronchial constriction, shock, pharyngeal constriction, shortness of
breath, unconsciousness, nausea, vomiting, shivers, and profuse
perspiration. Twenty control sera were from individuals who had
negative horsefly bite and wasp stinging tests. Sera were obtained
from 37 subjects with horsefly allergy in our previous study [16–17],
17 children (46%) age 6 to 18 years (mean 12.1 years) and 20 adults
(54%) age 19–59 years (mean 37.6 years), with immediate allergic
reactions after the bites of T. yao. All sera were stored at 280uC.
Collection of horsefly and SGE preparation
The procedures for the preparation of SGE (about 60 000,
average weight 0.17 g) from 10 kg horseflies of T. yao Macquart
and collection of horseflies were performed according to our
previous reported method [16–17]. The salivary glands were
excised and transferred into 0.1 M phosphate buffer solution,
pH 6.0 (PBS), and homogenized in the same solution containing
protease inhibitor cocktail and centrifuged at 5000 g for 10 min.
The supernatant was termed SGE and lyophilized. 4.1 g total
lyophilized SGE sample was obtained.
Vespa wasp venom collection
Venoms of V. magnifica were collected according to our previous
method [12,18]. Adult Vespa wasps were collected and subjected to
electronic stimulation (3–6 volts). Approximately 0.1 mg of venom
can be obtained from one adult worker wasp. After electronic
stimulation and venom collection, wasps were released. In total,
5 g of venom (wet weight) was obtained from about 50, 000
worker wasps.
Allergen purification from Vespa wasp venoms
Aliquots of Vespa wasp venoms (WV, 0.2 g) dissolved in 6 ml
0.1 M PBS, pH 6.0 were applied to a Sephadex G-75 (Superfine;
Amersham Biosciences; 2.66100 cm) gel filtration column and
eluted with the same buffer (Fig. 1A). Each fraction was subjected
to ELISA inhibition testing as described below. The eluted protein
peaks, which show ELISA inhibition activities were pooled and
purified further by cationic exchange columns of Resource S
(10 ml volume, Amersham Biosciences) and Mono S (1 ml
volume, Amersham Biosciences) as illustrated in Fig. 1B–F. The
purities of purified proteins were determined by SDS-PAGE. The
protein concentration was determined by a protein assay kit (Bio-
Rad, Hercules, CA) with BSA as a standard.
Structural analysis
The amino acid sequences of the N-terminus and partial
internal amino acid fragments recovered from the trypsin
hydrolysis were determined by automated Edman degradation
on an Applied Biosystems pulsed liquid-phase sequencer, model
491.
cDNA library construction and cDNA cloning
A cDNA library of the venom gland of V. magnifica was
constructed as previous described [19,20]. A PCR-based method
for high stringency screening of DNA libraries was used for
screening and isolating the clones. Specific primers in the sense
direction were designed according to the peptide sequences
determined by Edman degradation (Vesp ma 5: 59-AA(T/
C)AA(T/C)TA(T/C)TG(T/C)AG(A/G)AT(A/T/C)AA(A/G)TG-
39; Vesp ma 2: 59-TC(A/T/C/G)GA(A/G)AG(A/G)CC(A/G/C/
T)AA(A/G)AG(A/G)GT(A/G/C/T) TT-39) and primer II A (59-
AAGCAGTGGTATCAACGCAGAGT-39) in the antisense direc-
tion provided by the SMART
TM PCR cDNA synthesis kit were
used in PCR reactions. DNA sequencing was performed on an
Applied Biosystems DNA sequencer, model ABI PRISM 377.
Hyaluronidase assay
Hyaluronidase assays were performed for the detection of
hydrolysis of hyaluronic acid according to the method described
by our previous work. [16] Tested samples with different
concentrations were incubated with 30 mg/ml hyaluronic acid in
50 ml 10 mM Hepes buffer, pH 7.4 containing 0.15 M NaCl.
Reactions were stopped by adding 50 ml of freshly prepared 2.5%
cetylpyridinium chloride in 2% NaOH. The absorbance at
405 nm was measured after 5 min.
Immunoblot analysis with sera from patients with
horsefly or Vespa wasp allergy
Immunoblots for the detection of specific IgE binding were
p e r f o r m e dw i t hp u r i f i e dV e s pm a2a n dV e s pm a5o rh o r s e f l y
allergens (Tab y 2 and Tab y 5), which were purified from T. yao
Macquart [16], in allergic patients and 2 negative controls. Purified
allergens (3 mg) were loaded on an SDS-PAGE with a gel
concentrationof15% under reducing conditionsand then transferred
to nitrocellulose membranes. Membranes were incubated with sera
from patients (1:5 to 1:20 in PBS-Tween [1% BSA, 10% normal goat
serum]) for 90 min. After rinsing with PBS, the membranes were
incubated with monoclonal anti-human IgE (peroxidase-labeled
affinitypurifiedantibodytoHumanIgE,KPL,Inc.Maryland).Color
was developed by incubation of the membranes with substrate.
Enzyme-linked immunosorbent assay (ELISA)
96-well plates were coated overnight at 4uC with 100 ml per well
of 20 mg/ml SGE or WV in carbonate-bicarbonate buffer
(0.05 mol/l, pH 9.6). Human serum samples (1:50 dilution by
2% BSA, 0.05% Tween phosphate buffer saline) were pre-
incubated with different concentrations of purified allergens for
1 hour at 37uC, and added to the plates for 2 hours at room
temperature. Incubation of the diluted serum with saline was used
as a positive control. After IgE binding, plates were incubated with
horseradish peroxidase-labeled goat antihuman IgE (KPL, Inc.
Maryland, 1:2500), developed with tetramethylbenzidine peroxi-
dase substrate (KPL). The absorbance at 650 nm was monitored
on a microplate reader (Epoch Etock, BioTek).
Skin Prick Tests
For the skin prick testing, no patients were taking medications
(antihistamines, steroids, and other drugs) for at least 2 weeks.
They have no dermatographia or active skin disorders. Skin prick
tests were performed according to the standard procedure. The
skin prick reaction was read at 15 min. Wheal sizes were expressed
as the mean of the longest diameter and midpoint perpendicular
diameter. A skin prick test result was considered positive if the
mean wheal diameter was .3 mm.
Results
Purification of Vespa wasp allergens
As illustrated in Fig. 1A, the Vespa wasp venom was divided into
three fractions by Sephadex G-75 gel filtration. Fraction 1 was found
to contain binding activity with IgE from patient sera. Fraction 1 was
subjected to AKTA Resource S cationic exchange as illustrated in
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in Fig. 1B. Fraction 1.1 was found to contain hyaluronidase activity
and subjected to further purification by Mono S cationic exchange as
illustrated in Fig. 1C. Fraction 1.1.1 was the purified 35-KDa
hyaluronidase (Fig. 1E, Fig. S1). Fraction 1.5 in Fig. 1B was also
purified by Mono S cationic exchange as illustrated in Fig. 1D.
Fraction 1.5.1 was the purified 25-KDa Ag5 (Fig. 1F). The IUIS
Allergen Nomenclature Sub-Committee (www.allergen.org) has
assigned to this purified allergens, antigen 5 and hyaluronidase, the
following official numbers: Vesp ma 5 and Vesp ma 2, respectively.
cDNA cloning of Vespa wasp allergens
N-terminus and partial internal peptide fragments recovered
from trypsin hydrolysis of purified Vesp ma 2 and Vesp ma 5 are
illustrated in Fig. 2. Complete cDNA sequences encoding Vesp ma
5 and Vesp ma 2 were cloned from the wasp venom gland cDNA
library. The GenBank accession numbers of antigen 5 and
hyaluronidase were FR774918 and FR749885, respectively. The
proprotein of Vesp ma 5 is composed of 225 amino acid residues
(aa) including a predicted signal peptide (23 aa) and the mature
Vesp ma 5 (202 aa) (Fig. 2A). This protein was found to contain
Figure 1. Purification of allergens from the wasp venoms (WV), V. magnifica.A :WV aliquot of 0.2 g was applied to a Sephadex G-75 gel
filtration. The absorbance of the eluate was monitored at 280 nm. B: Fraction 1 from Sephadex G-75 gel filtration was subjected to AKTA Resource S
cationic exchange chromatography. The elution was performed at a flow rate of 1 ml/min with the indicated NaCl gradient. C: The first protein peak
after Resource S cationic exchange chromatography (peak 1.1) was subjected to AKTA Mono S cationic exchange chromatography. The elution was
performed at a flow rate of 1 ml/min with the indicated NaCl gradient. D: The fifth protein peak after Resource S cationic exchange chromatography
(peak 1.5) was subjected to AKTA Mono S cationic exchange chromatography. The elution was performed at a flow rate of 1 ml/min with the
indicated NaCl gradient. E&F : SDS-PAGE analysis of purified allergens of Vesp ma 5 and Vesp ma 2 in 15% gel concentration. R: reduced; NR: non-
reduced.
doi:10.1371/journal.pone.0031920.g001
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found in insect Ag5 proteins.
The proprotein of Vesp ma 2 is composed of 357 aa including a
predicted signal peptides (26 aa) and the mature Vesp ma 2 (331
aa) (Fig. 2B). As illustrated in Fig. S1, purified Vesp ma 2 showed
strong hydrolytic activity on hyaluronic acid in a time-dependent
manner.
IgE Immunoblot
Thirty and 31 of 33 (91.0% and 93.9%) of subjects’ sera with
Vespa wasp allergy reacted to Vesp ma 5 and Vesp ma 2,
respectively, as measured by the immunoblotting technique. IgE
immunoblots of a representative group of 8 patients and two
controls are presented in Fig. 3A–D. IgE binding was detected in
30 and 31 of 37 (81.1% and 83.8%) of subjects’ sera with horsefly
allergy using Vesp ma 5 and Vesp ma 2, respectively. Our
previous work showed that Tab y 5 and Tab y 2 reacted with 32
and 34 of 37 (86.5% and 91.8%) of subjects’ sera presenting
horsefly allergy, respectively. On the other hand, 27 and 26 of 33
(81.8% and 78.8%) of subjects’ sera with wasp allergy reacted to
Tab y 5 and Tab y 2, respectively, as assessed by IgE binding.
Fig. 3E shows that IgE binding was positive to three proteins
around 35 KDa, 34 KDa, and 25 KDa in patient sera. These
masses correspond to the molecular weight of Vesp ma 2, Tab y 5,
and Tab y 2, and were completely absent in all control subjects,
when these allergens were loaded on the same lane.
ELISA inhibition
For ELISA inhibition assays, the sera of three subjects (2, 3, and
8) which recognized Vesp ma 5, Vesp ma 2, Tab y 5, and Tab y 2
by immunoblot were chosen. All of these allergens could inhibit
the binding of the subjects’ IgE antibodies to the coated SGE and
WV. Four representative ELISA inhibitions are illustrated in
Fig. 4A–D. For example, the coated WV’s binding to the subjects’
IgE antibodies was inhibited by the WV, the SGE, Vesp ma 5,
Vesp ma 2, Tab y 5, and Tab y 2 in a dose-dependent manner
(Fig. 4A and B). Twenty mg/ml of WV could completely inhibit
IgE binding. The maximal inhibition by the SGE, Vesp ma 5,
Vesp ma 2, Tab y 5, and Tab y 2 was about 53.3, 39.5, 39.4, 24.6,
and 22.6%, respectively. Two wasp allergens (Vesp ma 5 and Vesp
ma 2) had stronger inhibitory ability to IgE binding with wasp
venom than these horsefly allergens (Tab y 5 and Tab y 2). In the
same situation, the coated SGE’s binding to the subjects’ IgE
antibodies was also inhibited by the WV, the SGE, Vesp ma 5,
Vesp ma 2, Tab y 5, and Tab y 2 in a dose-dependent manner
(Fig. 4C and D). 20 mg/ml of the SGE could achieve 100% of the
IgE inhibition whereas maximal inhibition by the WV, Vesp ma 5,
Vesp ma 2, Tab y 5, and Tab y 2 was about 57.9, 25.3, 23.8, 43.6,
and 40.6%, respectively. Two horsefly allergens (Tab y 5 and Tab
y 2) had stronger inhibitory ability in the IgE binding assay with
horsefly SGE than these wasp allergens (Vesp ma 5 and Vesp ma
2).
Skin Prick Tests
The results of the SPTs are shown in Table S1. Of the 15
patients with wasp allergy, 11, 12, 9 and 9 (73%, 80%, 60%, and
60%) patients had positive reactions to Vesp ma 5, Vesp ma 2,
Figure 2. cDNA encoding the Vesp ma 5 (A) and Vesp ma 2 (B)
from the wasp venom of V. magnifica and deduced amino acid
sequence. The amino acid sequences of peptide fragments deter-
mined by Edman degradation are underlined. The predicted signal
peptide is in italic. -: stop codon.
doi:10.1371/journal.pone.0031920.g002
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serum from patients with wasp allergy; Lanes I–VIII, representatives of subject serum from patients with horsefly allergy; Lanes 9 and 10, negative
controls. E: Three allergens (Vesp ma 5, Vesp ma 2, Tab y 2) were mixed and loaded on the same lane of SDS-PAGE (Left), and transferred to a
nitrocellulose membrane for immunoblotting (Right). Comassie blue staining was performed to visualize proteins after PAGE-SDS. Note: Tab y 5 was
not mixed with Vesp ma 5, Vesp ma 2, and Tab y 2 because it has the same molecular weight with Vesp ma 5.
doi:10.1371/journal.pone.0031920.g003
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allergy, 8, 10, 13 and 12 (53%, 67%, 87%, and 80%) patients had
positive reactions to Vesp ma 5, Vesp ma 2, Tab y 5 and Tab y 2,
respectively. The representatives of SPTs are illustrated in Figure
S2.
Discussion
In the present study, two major allergens are identified from the
venoms of the wasp V. magnifica. They are an antigen 5 (Vesp ma 5)
and a hyaluronidase (Vesp ma 2) protein, respectively.
There are more than 24 species in the wasp genus Vespa, but
allergens have been identified thus far only in Vespa crabro.
Hoffman and co-workers [7] reported four cases of allergic
reactions to V. crabro stings. They found 3 of 4 patients with known
reactions to V. crabro venom antigen 5. One patient was most
reactive with hyaluronidase. Phospholipase had relatively little
IgE-binding activity, although it is the major protein in this venom
[7]. Few allergens have been purified or cloned from V. crabro.
They are Vesp c 5 (Antigen 5) and Vesp c 1 (Phospholipase A1)
[6,7]. However, these two allergens’ allergenicity was poorly
understood. Thirty and 31 of 33 (91.0% and 93.9%) of subjects’
Figure 4. Cross ELISA inhibition of purified wasp and horsefly allergens with patients’ serum from subject 2, 3 and 8. A& B:2 0mg/ml
coated wasp venom’s binding with serum IgE from subject 2 (A) and 8 (B) was inhibited by wasp venom, horsefly SGE, Vesp ma 5, Vesp ma 2, Tab y 5,
and Tab y 2, respectively. C& D:2 0mg/ml coated horsefly SGE’s binding with serum IgE from subject 3 (C) and 8 (D) was inhibited by wasp venom,
horsefly SGE, Vesp ma 5, Vesp ma 2, Tab y 5, and Tab y 2, respectively. Inhibitor concentrations ranged from 10
25 mgt o2 0mg/ml. SGE: salivary gland
extracts; V-antigen: Vesp ma 5; V-hya: Vesp ma 2; S-antigen: Tab y 5; S-hya: Tab y 2.
doi:10.1371/journal.pone.0031920.g004
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respectively, by immunoblotting technique. Of the 15 patients
with wasp Vespa allergy, 11 and 12 (73%, and 80%) patients had
positive SPT reactions to Vesp ma 5 and Vesp ma 2 respectively.
It is likely that antigen 5 and hyaluronidase are also the major
allergens in Vespa wasp, as those from other vespid venom and
horsefly. Hyaluronidases are glycoside hydrolases that cleave b-
1,4-glycosidic bonds between the N-acetylglucosamine and the D-
glucuronic acid of hyaluronic acid, and thereby act as spreading
factors in Hymenoptera venoms [21–23]. Hyaluronidases have
been previously recognized as major allergens in the honeybee
venom, the yellow jacket venom, as well as from horsefly [21–23].
However, hyaluronidase has been recently shown to be only a
minor vespid allergen, at least in Vespula-allergic subjects. Most of
the IgE reactivity seen with hyaluronidase is directed against
carbohydrates (CCDs), and binding to hyaluronidase is seen
almost exclusively in wasp-honeybee double-positive patients
[24,25]. It is likely that high Ig E binding rate to Vesp ma 2 in
wasp venom-allergic patients in the present study might be caused
by protein epitopes as well as by CCDs.
Antigen 5 proteins belong to the CAP protein family including
cysteine-rich secretory proteins, insect antigen 5 proteins, and
plant pathogenesis-related proteins. Several Antigen 5 proteins
from hornets, wasps, horseflies, and fire ants are identified as
allergens [6,16,26–28]. They can induce acute hypersensitivity
responses in humans. No native Ag 5 protein has been purified
and characterized from Vespa wasps, and the current work is the
first to prove the presence of Ag 5-like protein (Vesp ma 5) with
IgE-binding ability in Vespa wasps.
Vesp ma 2 shares 92%, 91%, 73%, 54% and 41% sequence
similarity with the Dol m 2 from Dolichovespula maculate [28], Ves v 2
from Vespula vulgaris [29], Pol a 2 from Polistes annularies[30], Api m 2
from Apis mellifera [31], and Tab y 2 from Tabanus yao [16],
respectively. Hyaluronidases represent one of the most strongly
conserved Hymenoptera allergens and are also thought to be as one
of most important cross reactive allergens in yellow jacket and
honeybee venom [21]. Vesp ma 5 shares 87%, 72%, 68%, 65% and
27%sequencesimilaritywithVesp c5 from Vespacrabro[6],Dolm 5
from the Dolichovespula maculate [26], Ves v 5 from Vespula vulgaris
[27], Vesp m 5 from Vespula maculifrons [28], and Tab y5 from
Tabanus yao [16], respectively. Ag 5-like proteins are also strongly
conserved Hymenoptera allergens. Concomitant sensitization to
Hymenoptera venoms in subjects allergic to horseflies seems to be
frequent, since many cases of horsefly allergy have been recorded so
far [8–10]. Two years before, Quesrcia and co-workers [32]
suggested the wasp-horsefly syndrome based on two cases of two
male patients (57 and 62 years of age), who are already known as
allergic to stinging hymenoptera venom. After a horsefly bite, they
presented a serious 3–4 degree-type Mueller classification systemic
reaction [32]. No direct proof for the wasp-horsefly syndrome is
presented and no cross reactive allergen has been identified. We
have identified three allergens, Tab y 1, Tab y 2 and Tab y 5 from
horsefly, Tabanus yao Macquart [16,17]. The current work found
that these four allergens (Vesp ma 2 and Vesp ma 5, Tab y 2 and
Tab y 5), can induce allergic reactions in patients with allergy to
horseflies or wasps, and acted as cross reactive allergens between
allergy to horseflies and wasps. Immunoblots indicated that all these
four allergens bind to special IgE antibodies not only in the sera of
patients with horsefly allergy but also in those of the patients with
wasp allergy (Fig. 3A–D). In particular, three allergens (Vesp ma 2,
Tab y 5, and Tab y 2) can simultaneously bind to their
corresponding IgEs in patients with allergic reactions to horsefly
bites or wasp stings, providing further evidence that they are cross
reactive allergens for the horsefly-wasp syndrome (Fig. 3E). ELISA
inhibition showed that they could inhibit the binding of the subjects’
IgE antibodies to coated SGE or WV in a dose-dependent manner
(Fig. 4). Moreover, these four cross reactive allergens can induce
allergic reactions in allergic subjects by SPTs (Table 1 and Fig. S2).
All these results indicate that the current four allergens are
responsible for the horsefly-wasp syndrome and confirm the
existence of cross reactive allergens in both horsefly and wasp.
The venom hyaluronidases in hymenoptera are classical allergens
made responsible for cross-reactivity. Nevertheless, their IgE
reactivity is dominated by the pronounced cross-reactivity of
carbohydrate determinants (CCDs) [21]. According to simple
sequence analyses the Vesp ma 2 and Tab y 2 proteins contain 4
putative glycosylation sites and even the usually non-glycosylated
antigen 5,Taby 5,contains 2 putative glycosylationsites.It is highly
unlikely that these sites are completely devoid of glycans. This
information is potentially relevant, especially with regard to cross-
reactivity. Thus, IgE reactivity is not a parameter that can be taken
into account without excluding CCD-reactivities.
More than 50% of the IgE binding with the coated WV could be
inhibitedbytheSGE(Fig.4AandB),andmorethan60%oftheIgE
binding with the coated SGE could be inhibited by the WV (Fig. 4C
and D). The total IgE binding with the coated WV by both Tab y 5
and Tab y 2 does not exceed 45% (Fig. 4A and B), and the total IgE
binding with the coated SGE by both Vesp m 5 and m 2 does not
exceed50%(Fig.4C and D).Thissuggests that:(1)both thehorsefly
SGE and the wasp venom share a large proportion of cross reactive
allergens; and (2)in addition of these four crossallergens of Vesp ma
5, Vesp ma 2, Tab y 5, and Tab y2, there are other cross reactive
allergens in both the wasp and the horsefly.
In these ELISA inhibition assays, the maximal inhibition by one
of these four allergens was less than 43% (Fig. 4). These results
indicated that these allergens are important for the allergic
reactions induced by horsefly or wasp sting but there existed other
allergens in these organisms. Several lines of evidences have
indicated that there are multiple allergens in the same organism.
At least eight allergens were predicted to be in the saliva of Aedes
aegypti [33–35]. There are more than four types of allergens in the
venoms of the wasp Polistes gallicus [8]. In order to develop highly
sensitive immunoassays for the diagnosis of horsefly or wasp
allergy and effectively treat the individual who is sensitized by the
particular allergen(s), further work is necessary to identify and
characterize all of the allergens in these organisms.
Supporting Information
Figure S1 Hyaluronidase activity of Vesp ma 2.
(TIF)
Figure S2 Representative results of SPTs.
(TIF)
Table S1 Results of skin prick tests using purified
allergens.
(DOC)
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